Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01582516
Recruitment Status : Completed
First Posted : April 20, 2012
Last Update Posted : March 9, 2015
Sponsor:
Collaborator:
VU University Medical Center
Information provided by (Responsible Party):
C.Dirven, Erasmus Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014